Genetic Testing Market Size

  • Report ID: 4745
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Genetic Testing Market Size

Genetic Testing Market size was over USD 22.74 billion in 2024 and is projected to cross USD 72.05 billion by the end of 2037, witnessing more than 9.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of genetic testing is estimated at USD 24.43 billion.

The reason behind the growth is impelled by the rising prevalence of hereditary illnesses. The prevalence of hereditary illnesses is rising as a result of a lack of understanding of the usefulness of genetic testing.

Patients could use genetic testing to help them make crucial decisions about the early diagnosis, treatment, or prevention of hereditary illnesses. For instance, more than 250,000 kids worldwide are born with sickle cell disease each year, and the disease affects over 4% of the world's population.

The growing popularity of personalized medicine is believed to fuel the market growth. Personalized medicine is becoming incredibly popular, since it helps patients' prognoses and therapies to be more effective, and is a fresh and improved method of treating patients that is based on the individual genetic composition of each patient. Personalized medicine uses genetic testing to enable providers to better serve their patients, advance precision and personalized medicine, and increase patient outcomes.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4745
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of genetic testing is estimated at USD 24.43 billion.

The genetic testing market size was over USD 22.74 billion in 2024 and is projected to cross USD 72.05 billion by the end of 2037, witnessing more than 9.2% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of hereditary illnesses and the growing popularity of personalized medicine will boost the market growth.

Asia Pacific industry is predicted to account for the largest share of 36% by 2037, impelled by growing healthcare sector in the region.

The major players in the market include Genentech Inc., Sorenson Genomics, Abbott Molecular, Bayer AG, Biocartis, BioHelix, Quest Diagnostics, Exact Sciences Corporation, HTG Molecular Diagnostics, Inc., PacBio.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample